Immunosuppressant Medication Dosed Daily After Kidney Transplant

Stopped early · Early Phase 1

Conditions studied: Kidney Transplant Rejection, Medication Adherence

In brief

Medication non-adherence is a major risk factor for graft dysfunction and graft loss among pediatric and adult transplant recipients. Rates of non-adherence in these populations are estimated between 30 and 70%, with the highest prevalence in adolescent and young adult (AYA) transplant recipients. Treatment-related factors known to impact rates of adherence include the number of medication doses per day and the number of tablets or capsules a patient takes per day, or "pill burden". One approach to minimizing dosing frequency and pill-burden includes transitioning patients to once-daily formulations. The current literature investigating utilization of once-daily immunosuppressive regimens in the AYA kidney transplant population is limited.

Key facts

Study ID
NCT04156204
Run by
University of Colorado, Denver
People needed
1
Starts
2019-11-20
Expected to finish
2020-11-27
Last updated by the study team
2020-12-02

Who can join

Age: 13 and older, up to 22. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.